PKD2 Antikörper (pSer812)
Kurzübersicht für PKD2 Antikörper (pSer812) (ABIN7182463)
Target
Alle PKD2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- pSer812
-
Verwendungszweck
- Phospho-PKD2 (S812) Antibody
-
Kreuzreaktivität
- Maus, Ratte
-
Aufreinigung
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
-
Immunogen
- Synthesized peptide derived from Human PKD2 around the phosphorylation site of S812.
-
Isotyp
- IgG
-
-
anti-Polycystic Kidney Disease 2 (Autosomal Dominant) (PKD2) (AA 261-360) antibody
PKD2 Reaktivität: Human WB, ELISA, IF Wirt: Maus Monoclonal 4C8 unconjugated
anti-Polycystic Kidney Disease 2 (Autosomal Dominant) (PKD2) (AA 621-832) antibodyPKD2 Reaktivität: Human WB, ELISA, IHC (p), ICC, IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
anti-Polycystic Kidney Disease 2 (Autosomal Dominant) (PKD2) (AA 327-539) antibodyPKD2 Reaktivität: Maus WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Polycystic Kidney Disease 2 (Autosomal Dominant) (PKD2) (AA 240-410) antibodyPKD2 Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-Polycystic Kidney Disease 2 (Autosomal Dominant) (PKD2) (AA 680-968) antibodyPKD2 Reaktivität: Human ELISA, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Polycystic Kidney Disease 2 (Autosomal Dominant) (PKD2) (pSer876) antibodyPKD2 Reaktivität: Human, Maus, Ratte WB, ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Polycystic Kidney Disease 2 (Autosomal Dominant) (PKD2) (AA 937-968), (C-Term) antibodyPKD2 Reaktivität: Human WB, IHC (p) Wirt: Kaninchen Polyclonal RB1352 unconjugated
anti-Polycystic Kidney Disease 2 (Autosomal Dominant) (PKD2) (AA 261-360) antibodyPKD2 Reaktivität: Human WB, ELISA Wirt: Maus Monoclonal 1G3 unconjugated
anti-Polycystic Kidney Disease 2 (Autosomal Dominant) (PKD2) (AA 914-927), (Intracellular) antibodyPKD2 Reaktivität: Human WB, IHC, IF, IC Wirt: Kaninchen Polyclonal unconjugated
anti-Polycystic Kidney Disease 2 (Autosomal Dominant) (PKD2) (Tyr654) antibodyPKD2 Reaktivität: Human, Maus, Ratte WB, ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- PKD2 (Polycystic Kidney Disease 2 (Autosomal Dominant) (PKD2))
-
Andere Bezeichnung
- PKD2
-
Hintergrund
- APKD2 antibody, Autosomal dominant polycystic kidney disease type II antibody, Autosomal dominant polycystic kidney disease type II protein antibody, MGC138466 antibody, MGC138468 antibody, PC 2 antibody, PC2 antibody, PKD 2 antibody, PKD2 antibody, PKD2_HUMAN antibody, PKD4 antibody, Polycystic kidney disease 2 (autosomal dominant) antibody, Polycystic kidney disease 2 antibody, Polycystic kidney disease 2 protein antibody, Polycystin 2 antibody, Polycystin 2 transient receptor potential cation channel antibody, Polycystin-2 antibody, Polycystin2 antibody, Polycystwin antibody, R48321 antibody, Transient receptor potential cation channel subfamily P member 2 antibody, TRPP2 antibody
-
UniProt
- Q13563
-
Pathways
- cAMP Metabolic Process, Maintenance of Protein Location, Negative Regulation of Transporter Activity
Target
-
